Pradhan Mantri Bhartiya Janaushadhi Pariyojana
- September 17, 2022
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Pradhan Mantri Bhartiya Janaushadhi Pariyojana
Subject : Government schemes
Context:
The government launched diabetes drug Sitagliptin and its combinations at various rates which will be sold at generic pharmacy stores, Janaushadhi Kendras.
Details:
- Sitagliptin phosphate tablets 50 mg (100 mg) -Rs 60 (rs100)/10 tablets,
- Combination of Sitagliptin and Metformin Hydrochloride tablets of 50mg/500mg -Rs 65 for a pack of ten
- Sitagliptin Metformin hydrochloride tablets of 50mg/1000mg – Rs 70 for the same quantity.
- It would improve glycemic control in adults with type 2 diabetes mellitus.
- Diabetes mellitus refers to a group of diseases that affect how the body uses blood sugar (glucose).
Concept:
Diabetes-Diabetes is a condition that impairs the body’s ability to process blood glucose, otherwise known as blood sugar.
Types
- Type I diabetes: Also known as juvenile diabetes, this type occurs when the body fails to produce insulin. People with type I diabetes are insulin-dependent, which means they must take artificial insulin daily to stay alive.
- Type 2 diabetes: It affects the way the body uses insulin. While the body still makes insulin, unlike in type I, the cells in the body do not respond to it as effectively as they once did.
- This is the most common type of diabetes and it has strong links with obesity.
- Gestational diabetes: This type occurs in women during pregnancy when the body can become less sensitive to insulin. Gestational diabetes does not occur in all women and usually resolves after giving birth.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana
- It is a campaign launched by the Department of Pharmaceuticals of the Ministry of Chemicals and Fertilizers.
- It seeks to provide quality medicines at affordable prices to the masses through special kendra’s known as Pradhan Mantri Bhartiya Jan Aushadhi Kendra.
- Initially launched in 2008, the scheme was rechristened in 2015.
- Bureau of Pharma PSUs of India (BPPI) is the implementation agency for PMBJP.
- The Bureau of Pharma Public Sector Undertakings (PSUs) of India works under the Ministry of Chemicals & Fertilisers.
- Objective of the PMBJP:
- To make available quality medicines, consumables and surgical items at affordable prices for all and reduce out of pocket expenditure of consumers/patients.
- To popularise generic medicines among the masses and dispel the prevalent notion that low priced generic medicines are of inferior quality or are less effective.
- Generic medicines are unbranded medicines which are equally safe and have the same efficacy as that of branded medicines in terms of their therapeutic value.
- To ensure easy availability of the menstrual health services (Janaushadhi ‘Suvidha’ sanitary napkins) to all women across India.
- Generate employment by engaging individual entrepreneurs in the opening of PMBJP Kendras.
- Janaushadhi Kendra?
- These are the centres from where quality generic medicines are made available to all.
- Bureau of Pharma PSUs in India (BPPI) supports Janaushadhi Kendras as a part of PMBJP.
- The Government has set a target to increase the number of Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) to 10,500 by the end of March 2025.